Advertisement

Promoting the Behavioral Health of Persons with Neurocognitive Disorders

  • Jonathan Singer
  • Adrienne Chong
  • Ryan Hisaka
  • Jane E. Fisher
Chapter

Abstract

It is projected that the number of individuals with dementia will continue to increase over the next several decades, with no cure in sight. Consequently, a greater understanding of how to promote behavioral health and quality of life for these individuals is becoming increasingly important. A common approach in the field is symptom management through pharmacologic approaches to cognitive enhancement and treatment of behavioral changes. Rather than a purely medical approach to dementia care, interventions to improve quality of life should involve comprehensive, integrated care. This chapter discusses literature that describes an integrated, contextual model of dementia care, in which comorbid conditions are appropriately treated, adaptive behaviors are supported, and excess disability is rectified or prevented. Within the context of this model of dementia care, the current chapter also describes the importance of family caregiver quality of life and neurocognitive education, in order to improve treatment for individuals suffering from this insidious disease.

Keywords

Behavioral health Neurocognitive disorders Integrated care Quality of life Caregiver 

References

  1. Abbott, R. A., Whear, R., Rodgers, L. R., Bethel, A., Coon, J. T., Kuyken, W., … Dickens, C. (2014). Effectiveness of mindfulness-based stress reduction and mindfulness based cognitive therapy in vascular disease: A systematic review and meta-analysis of randomised controlled trials. Journal of Psychosomatic Research, 76(5), 341–351.CrossRefPubMedGoogle Scholar
  2. Abizanda, P., Romero, L., Sanchez-Jurado, P. M., Martinez-Reig, M., Alfonso-Silguero, S. A., & Rodriguez-Manas, L. (2014). Age, frailty, disability, institutionalization, multimorbidity or comorbidity. Which are the main targets in older adults? The Journal of Nutrition, Health & Aging, 18(6), 622.CrossRefGoogle Scholar
  3. Achterberg, W. P., Pieper, M. J., van Dalen-Kok, A. H., De Waal, M. W., Husebø, B., Lautenbacher, S., … Corbett, A. (2013). Pain management in patients with dementia. Clinical Interventions in Aging, 8, 1471–1482.CrossRefPubMedGoogle Scholar
  4. Alexopoulos, G. S. (2005). Depression in the elderly. The Lancet, 365(9475), 1961–1970.CrossRefGoogle Scholar
  5. Alliance, F. C. (2012). Fact sheet: Selected caregiver statistics. San Francisco, CA: Family Caregiver Alliance.Google Scholar
  6. American Psychological Association. (2017). Integrated Health Care. Retrieved from http://www.apa.org/health/integrated-health-care.aspx
  7. Andreassi, J. L. (2013). Psychophysiology: Human behavior & physiological response. Mahwah, NJ: Lawrence Erlbaum Associates, Inc.Google Scholar
  8. Baert, V., Gorus, E., Mets, T., Geerts, C., & Bautmans, I. (2011). Motivators and barriers for physical activity in the oldest old: A systematic review. Ageing Research Reviews, 10(4), 464–474.CrossRefPubMedGoogle Scholar
  9. Ballard, C., Hanney, M. L., Theodoulou, M., Douglas, S., McShane, R., Kossakowski, K., … Jacoby, R. (2009). The dementia antipsychotic withdrawal trial (DART-AD): Long-term follow-up of a randomised placebo-controlled trial. The Lancet Neurology, 8(2), 151–157.CrossRefPubMedGoogle Scholar
  10. Ballard, C., Smith, J., Corbett, A., Husebo, B., & Aarsland, D. (2011). The role of pain treatment in managing the behavioural and psychological symptoms of dementia (BPSD). International Journal of Palliative Nursing, 17(9), 420–424.CrossRefPubMedGoogle Scholar
  11. Bandurska, E., Damps-Konstanska, I., Popowski, P., Jedrzejczyk, T., Janowiak, P., Swietnicka, K., … Jassem, E. (2017). Impact of Integrated Care Model (ICM) on Direct Medical Costs in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD). Medical Science Monitor, 23, 2850–2862.CrossRefPubMedGoogle Scholar
  12. Barker, W. W., Luis, C. A., Kashuba, A., Luis, M., Harwood, D. G., Loewenstein, D., … Graff-Radford, N. (2002). Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the state of Florida brain Bank. Alzheimer Disease & Associated Disorders, 16(4), 203–212.CrossRefGoogle Scholar
  13. Bauman, A., Merom, D., Bull, F. C., Buchner, D. M., & Fiatarone Singh, M. A. (2016). Updating the evidence for physical activity: Summative reviews of the epidemiological evidence, prevalence, and interventions to promote “active aging”. The Gerontologist, 56(Suppl_2), S268–S280.CrossRefPubMedGoogle Scholar
  14. Beach, T. G., Monsell, S. E., Phillips, L. E., & Kukull, W. (2012). Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer disease centers, 2005–2010. Journal of Neuropathology & Experimental Neurology, 71(4), 266–273.CrossRefGoogle Scholar
  15. Beerens, H. C., Sutcliffe, C., Renom-Guiteras, A., Soto, M. E., Suhonen, R., Zabalegui, A., … RightTimePlaceCare Consortium. (2014). Quality of life and quality of care for people with dementia receiving long term institutional care or professional home care: The European RightTimePlaceCare study. Journal of the American Medical Directors Association, 15(1), 54–61.CrossRefPubMedGoogle Scholar
  16. Beerens, H. C., Zwakhalen, S. M., Verbeek, H., Ruwaard, D., & Hamers, J. P. (2013). Factors associated with quality of life of people with dementia in long-term care facilities: A systematic review. International Journal of Nursing Studies, 50(9), 1259–1270.CrossRefPubMedGoogle Scholar
  17. Bond, M., Rogers, G., Peters, J., Anderson, R., Hoyle, M., Miners, A., … Jeffreys, M. (2012). The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of technology appraisal no. 111): A systematic review and economic model. Health Technology Assessment (Winchester, England), 16(21), 1–470.Google Scholar
  18. Boustani, M., Peterson, B., Hanson, L., Harris, R., & Lohr, K. N. (2003). Screening for dementia in primary care: A summary of the evidence for the US preventive services task force. Annals of Internal Medicine, 138(11), 927–937.CrossRefPubMedGoogle Scholar
  19. Bowling, A. (2001). Measuring disease. In A review of disease-specific quality of life measurement scales. Buckingham, UK: Open University Press.Google Scholar
  20. Bowling, A., Rowe, G., Adams, S., Sands, P., Samsi, K., Crane, M., … Manthorpe, J. (2015). Quality of life in dementia: A systematically conducted narrative review of dementia-specific measurement scales. Aging & Mental Health, 19(1), 13–31.CrossRefGoogle Scholar
  21. Brown, L. G. (2016). Untangling polypharmacy in older adults. Medsurg Nursing, 25(6), 408–412.Google Scholar
  22. Brown, R. C., Lockwood, A. H., & Sonawane, B. R. (2005). Neurodegenerative diseases: An overview of environmental risk factors. Environmental Health Perspectives, 113(9), 1250–1256.CrossRefPubMedGoogle Scholar
  23. Buchanan, J. A., Christenson, A., Houlihan, D., & Ostrom, C. (2011). The role of behavior analysis in the rehabilitation of persons with dementia. Behavior Therapy, 42(1), 9–21.CrossRefPubMedGoogle Scholar
  24. Campanelli, C. M. (2012). American Geriatrics Society updated beers criteria for potentially inappropriate medication use in older adults: The American Geriatrics Society 2012 beers criteria update expert panel. Journal of the American Geriatrics Society, 60(4), 616.CrossRefGoogle Scholar
  25. Catania, A. C. (1996). On the origins of behavior structure. Advances in Psychology, 117, 3–12.CrossRefGoogle Scholar
  26. Centers for Medicare & Medicaid Services. (2013). Atypical Antipsychotic Medications: Use in Adults. Retrieved from https://www.cms.gov/medicaremedicaid-coordination/fraud-prevention/medicaid-integrity-education/pharmacy-education-materials/downloads/atyp-antipsych-adult-factsheet.pdf
  27. Chapman, D. P., Williams, S. M., Strine, T. W., Anda, R. F., & Moore, M. J. (2006). Dementia and its implications for public health. Preventing Chronic Disease, 3(2), A34.Google Scholar
  28. Chiu, Y., Bero, L., Hessol, N. A., Lexchin, J., & Harrington, C. (2015). A literature review of clinical outcomes associated with antipsychotic medication use in north American nursing home residents. Health Policy, 119(6), 802–813.CrossRefPubMedGoogle Scholar
  29. Clague, F., Mercer, S. W., McLean, G., Reynish, E., & Guthrie, B. (2016). Comorbidity and polypharmacy in people with dementia: Insights from a large, population-based cross-sectional analysis of primary care data. Age and Ageing, 46(1), 33–39.Google Scholar
  30. Dawson, P., Wells, D. L., & Kline, K. (1993). Enhancing the abilities of persons with Alzheimer’s and related dementias: A nursing perspective. New York, NY: Springer Publishing Company.Google Scholar
  31. Di Santo, S. G., Prinelli, F., Adorni, F., Caltagirone, C., & Musicco, M. (2013). A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer’s disease. Journal of Alzheimer’s Disease, 35(2), 349–361.CrossRefPubMedGoogle Scholar
  32. Doody, R. S., Stevens, J. C., Beck, C., Dubinsky, R. M., Kaye, J. A., Gwyther, L. M. S. W., … Cummings, J. L. (2001). Practice parameter: Management of dementia (an evidence-based review) report of the quality standards Subcommittee of the American Academy of neurology. Neurology, 56(9), 1154–1166.CrossRefPubMedGoogle Scholar
  33. Dramé, M., Fierobe, F., Lang, P. O., Jolly, D., Boyer, F., Mahmoudi, R., … Voisin, T. (2011). Predictors of institution admission in the year following acute hospitalisation of elderly people. The Journal of Nutrition. Health & Aging, 15(5), 399–403.Google Scholar
  34. Enns, E., Rhemtulla, R., Ewa, V., Fruetel, K., & Holroyd-Leduc, J. M. (2014). A controlled quality improvement trial to reduce the use of physical restraints in older hospitalized adults. Journal of the American Geriatrics Society, 62(3), 541–545.CrossRefPubMedGoogle Scholar
  35. Fauth, E. B., & Gibbons, A. (2014). Which behavioral and psychological symptoms of dementia are the most problematic? Variability by prevalence, intensity, distress ratings, and associations with caregiver depressive symptoms. International Journal of Geriatric Psychiatry, 29(3), 263–271.CrossRefPubMedGoogle Scholar
  36. Fisher, J. E., Drossel, C., Yury, C., & Cherup, S. (2007). A contextual model of restraint–free care for persons with dementia. In P. Sturmey (Ed.), Functional analysis in clinical treatment (pp. 211–238). San Diego, CA: Elsevier.CrossRefGoogle Scholar
  37. Fleming, R., Goodenough, B., Low, L. F., Chenoweth, L., & Brodaty, H. (2016). The relationship between the quality of the built environment and the quality of life of people with dementia in residential care. Dementia, 15(4), 663–680.CrossRefPubMedGoogle Scholar
  38. Gallagher-Thompson, D., Tzuang, Y. M., Au, A., Brodaty, H., Charlesworth, G., Gupta, R., … Shyu, Y. I. (2012). International perspectives on nonpharmacological best practices for dementia family caregivers: A review. Clinical Gerontologist, 35(4), 316–355.CrossRefGoogle Scholar
  39. Galvin, J. E., & Sadowsky, C. H. (2012). Practical guidelines for the recognition and diagnosis of dementia. The Journal of the American Board of Family Medicine, 25(3), 367–382.CrossRefPubMedGoogle Scholar
  40. Garrison-Diehn, C., Rummel, C., & Fisher, J. E. (2013). A contextual approach to dementia Care in Alzheimer’s disease. In Case studies in clinical psychological science: Bridging the gap from science to practice (p. 279). Oxford, NY: Oxford University Press.Google Scholar
  41. Geldmacher, D. S. (2003). Alzheimer’s disease: Current pharmacotherapy in the context of patient and family needs. Journal of the American Geriatrics Society, 51(5s2), S289–S295.CrossRefPubMedGoogle Scholar
  42. Gitlin, L. N., Kales, H. C., & Lyketsos, C. G. (2012). Nonpharmacologic management of behavioral symptoms in dementia. JAMA, 308(19), 2020–2029.CrossRefPubMedGoogle Scholar
  43. Gitlin, L. N., Winter, L., Dennis, M. P., Hodgson, N., & Hauck, W. W. (2010). A biobehavioral home-based intervention and the Well-being of patients with dementia and their caregivers: The COPE randomized trial. JAMA, 304(9), 983–991.CrossRefPubMedGoogle Scholar
  44. Gnjidic, D., Hilmer, S. N., Blyth, F. M., Naganathan, V., Waite, L., Seibel, M. J., … Le Couteur, D. G. (2012). Polypharmacy cutoff and outcomes: Five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. Journal of Clinical Epidemiology, 65(9), 989–995.CrossRefPubMedGoogle Scholar
  45. Goodarzi, Z. S., Mele, B. S., Roberts, D. J., & Holroyd-Leduc, J. (2017). Depression case finding in individuals with dementia: A systematic review and meta-analysis. Journal of the American Geriatrics Society., 65(5), 937.CrossRefPubMedGoogle Scholar
  46. Gu, J., Strauss, C., Bond, R., & Cavanagh, K. (2015). How do mindfulness-based cognitive therapy and mindfulness-based stress reduction improve mental health and wellbeing? A systematic review and meta-analysis of mediation studies. Clinical Psychology Review, 37, 1–12.CrossRefPubMedGoogle Scholar
  47. Hebert, L. E., Weuve, J., Scherr, P. A., & Evans, D. A. (2013). Alzheimer disease in the United States (2010–2050) estimated using the 2010 census. Neurology, 80(19), 1778–1783.CrossRefPubMedGoogle Scholar
  48. Hilton, L., Hempel, S., Ewing, B. A., Apaydin, E., Xenakis, L., Newberry, S., … Maglione, M. A. (2017). Mindfulness meditation for chronic pain: Systematic review and meta-analysis. Annals of Behavioral Medicine, 51(2), 199–213.CrossRefPubMedGoogle Scholar
  49. Holland, J. M., Currier, J. M., & Gallagher-Thompson, D. (2009). Outcomes from the resources for enhancing Alzheimer’s caregiver health (REACH) program for bereaved caregivers. Psychology and Aging, 24(1), 190.CrossRefPubMedGoogle Scholar
  50. Hovstadius, B., & Petersson, G. (2012). Factors leading to excessive polypharmacy. Clinics in Geriatric Medicine, 29(2), 159–172.CrossRefPubMedGoogle Scholar
  51. Husebo, B. S., Strand, L. I., Moe-Nilssen, R., BorgeHusebo, S., Aarsland, D., & Ljunggren, A. E. (2008). Who suffers most? Dementia and pain in nursing home patients: A cross-sectional study. Journal of the American Medical Directors Association, 9(6), 427–433.CrossRefPubMedGoogle Scholar
  52. Jellinger, K. A., & Attems, J. (2011). Prevalence and pathology of dementia with Lewy bodies in the oldest old: A comparison with other dementing disorders. Dementia and Geriatric Cognitive Disorders, 31(4), 309–316.CrossRefPubMedGoogle Scholar
  53. Judge, K. S., Yarry, S. J., Looman, W. J., & Bass, D. M. (2013). Improved strain and psychosocial outcomes for caregivers of individuals with dementia: Findings from project ANSWERS. The Gerontologist, 53(2), 280–292.CrossRefPubMedGoogle Scholar
  54. Kales, H. C., Gitlin, L. N., & Lyketsos, C. G. (2015). State of the art review: Assessment and management of behavioral and psychological symptoms of dementia. The BMJ, 350, h369.CrossRefPubMedGoogle Scholar
  55. Kim, D. H., Brown, R. T., Ding, E. L., Kiel, D. P., & Berry, S. D. (2011). Dementia medications and risk of falls, syncope, and related adverse events: Meta-analysis of randomized controlled trials. Journal of the American Geriatrics Society, 59(6), 1019–1031.CrossRefPubMedGoogle Scholar
  56. Knapskog, A. B., Barca, M. L., & Engedal, K. (2014). Prevalence of depression among memory clinic patients as measured by the Cornell scale of depression in dementia. Aging & Mental Health, 18(5), 579–587.CrossRefGoogle Scholar
  57. Lambert, M. A., Bickel, H., Prince, M., Fratiglioni, L., Von Strauss, E., Frydecka, D., … Reynish, E. L. (2014). Estimating the burden of early onset dementia; systematic review of disease prevalence. European Journal of Neurology, 21(4), 563–569.CrossRefPubMedGoogle Scholar
  58. Lauche, R., Cramer, H., Dobos, G., Langhorst, J., & Schmidt, S. (2013). A systematic review and meta-analysis of mindfulness-based stress reduction for the fibromyalgia syndrome. Journal of Psychosomatic Research, 75(6), 500–510.CrossRefPubMedGoogle Scholar
  59. LoGiudice, D., & Watson, R. (2014). Dementia in older people: An update. Internal Medicine Journal, 44(11), 1066–1073.CrossRefPubMedGoogle Scholar
  60. Looman, W. M., Huijsman, R., Bouwmans-Frijters, C. A., Stolk, E. A., & Fabbricotti, I. N. (2016). Cost-effectiveness of the ‘Walcheren integrated care Model’intervention for community-dwelling frail elderly. Family Practice, 33(2), 154–160.CrossRefPubMedGoogle Scholar
  61. Lopez, O. L., Becker, J. T., Wahed, A. S., Saxton, J., Sweet, R. A., Wolk, D. A., … Dekosky, S. T. (2009). Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease. Journal of Neurology, Neurosurgery & Psychiatry, 80(6), 600–607.CrossRefGoogle Scholar
  62. Lwi, S. J., Ford, B. Q., Casey, J. J., Miller, B. L., & Levenson, R. W. (2017). Poor caregiver mental health predicts mortalilty of patients with neurodegenerative disease. Proceedings of the National Academy of Science, 201701597. https://doi.org/10.1073/pnas.1701597114 CrossRefGoogle Scholar
  63. Marcum, Z. A., Driessen, J., Thorpe, C. T., Gellad, W. F., & Donohue, J. M. (2014). Effect of multiple pharmacy use on medication adherence and drug–drug interactions in older adults with Medicare part D. Journal of the American Geriatrics Society, 62(2), 244–252.CrossRefPubMedGoogle Scholar
  64. Maust, D. T., Kim, H. M., Seyfried, L. S., Chiang, C., Kavanagh, J., Schneider, L. S., & Kales, H. C. (2015). Antipsychotics, other psychotropics, and the risk of death in patients with dementia: Number needed to harm. JAMA Psychiatry, 72(5), 438–445.CrossRefPubMedGoogle Scholar
  65. McKhann, G. M., Albert, M. S., & Sperling, R. A. (2012). Changing diagnostic concepts of Alzheimer’s disease. In Alzheimer’s Disease-Modernizing Concept, Biological Diagnosis and Therapy, 28, 115–121 Karger Publishers.Google Scholar
  66. McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., … Mohs, R. C. (2011). The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia, 7(3), 263–269.CrossRefGoogle Scholar
  67. Molinari, V., Chiriboga, D., Branch, L. G., Cho, S., Turner, K., Guo, J., & Hyer, K. (2010). Provision of psychopharmacological services in nursing homes. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 65(1), 57–60.CrossRefGoogle Scholar
  68. Molinari, V. A. (2006). Caregiver burden. In S. M. Lobo Prabhu, V. A. Molinari, & J. W. Lomax (Eds.), Supporting the caregiver in dementia: A guide for health care professionals (pp. 64–81). Baltimore, MD: The Johns Hopkins University Press.Google Scholar
  69. Moss, K., Scogin, F., Di Napoli, E., & Presnell, A. (2012). A self-help behavioral activation treatment for geriatric depressive symptoms. Aging & Mental Health, 16(5), 625–635.CrossRefGoogle Scholar
  70. Neufeld, R. R., Libow, L. S., Foley, W. J., Dunbar, J. M., Cohen, C., & Breuer, B. (1999). Restraint reduction reduces serious injuries among nursing home residents. Journal of the American Geriatrics Society, 47(10), 1202–1207.CrossRefPubMedGoogle Scholar
  71. Norgaard, A., Jensen-Dahm, C., Gasse, C., Hansen, E. S., & Waldemar, G. (2017). Psychotropic polypharmacy in patients with dementia: Prevalence and predictors. Journal of Alzheimer’s Disease, 56(2), 707–716.CrossRefPubMedGoogle Scholar
  72. Odenheimer, G., Borson, S., Sanders, A. E., Swain-Eng, R. J., Kyomen, H. H., Tierney, S., … Johnson, J. (2013). Quality improvement in neurology dementia management quality measures. Neurology, 81(17), 1545–1549.CrossRefPubMedGoogle Scholar
  73. Paller, K. A., Creery, J. D., Florczak, S. M., Weintraub, S., Mesulam, M. M., Reber, P. J., ... O’Hara, M. (2015). Benefits of mindfulness training for patients with progressive cognitive decline and their caregivers. American Journal of Alzheimer’s Disease & Other Dementias®, 30(3), 257–267.CrossRefGoogle Scholar
  74. Paterson, R. W., Takada, L. T., & Geschwind, M. D. (2012). Diagnosis and treatment of rapidly progressive dementias. Neurology: Clinical Practice, 2(3), 187–200.Google Scholar
  75. Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013). The global prevalence of dementia: A systematic review and metaanalysis. Alzheimer’s & Dementia, 9(1), 63–75.CrossRefGoogle Scholar
  76. Prince, M., Comas-Herrera, A., Knapp, M., Guerchet, M., & Karagiannidou, M. (2016). World Alzheimer report 2016: Improving healthcare for people living with dementia: Coverage, quality and costs now and in the future. London, UK: Alzheimer’s Disease International (ADI).Google Scholar
  77. Rahman, S. (2017). Enhancing health and wellbeing in dementia: A person-centered integrated care approach. London, UK: Jessica Kingsley Publishers.Google Scholar
  78. Riley, K. E., & Kalichman, S. (2015). Mindfulness-based stress reduction for people living with HIV/AIDS: Preliminary review of intervention trial methodologies and findings. Health Psychology Review, 9(2), 224–243.CrossRefPubMedGoogle Scholar
  79. Rizzi, L., Rosset, I., & Roriz-Cruz, M. (2014). Global epidemiology of dementia: Alzheimer’s and vascular types. BioMed Research International, 2014, 8.CrossRefGoogle Scholar
  80. Rolland, Y., Pillard, F., Klapouszczak, A., Reynish, E., Thomas, D., Andrieu, S., … Vellas, B. (2007). Exercise program for nursing home residents with Alzheimer’s disease: A 1-year randomized, controlled trial. Journal of the American Geriatrics Society, 55(2), 158–165.CrossRefPubMedGoogle Scholar
  81. Rush, S. E., & Sharma, M. (2016). Mindfulness-based stress reduction as a stress management intervention for cancer care: A systematic review. Journal of Evidence-Based Complementary & Alternative Medicine., 2156587216661467, 22(2), 348–360.CrossRefGoogle Scholar
  82. Schneider, L. S., Dagerman, K. S., & Insel, P. (2005). Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. JAMA, 294(15), 1934–1943.CrossRefPubMedGoogle Scholar
  83. Schultz, R., Belle, S. H., Czaja, S. J., Gitlin, L. N., Wisniewski, S. R., & Ory, M. G. (2003). Introduction to the special section on resources for enhancing Alzheimer’s caregiver health (REACH). Psychology and Aging, 18(3), 357.CrossRefGoogle Scholar
  84. Snarski, M., Scogin, F., DiNapoli, E., Presnell, A., McAlpine, J., & Marcinak, J. (2011). The effects of behavioral activation therapy with inpatient geriatric psychiatry patients. Behavior Therapy, 42(1), 100–108.CrossRefPubMedGoogle Scholar
  85. Snowden, M. B., Atkins, D. C., Steinman, L. E., Bell, J. F., Bryant, L. L., Copeland, C., & Fitzpatrick, A. L. (2015). Longitudinal association of dementia and depression. The American Journal of Geriatric Psychiatry, 23(9), 897–905.CrossRefPubMedGoogle Scholar
  86. Tampi, R. R., Tampi, D. J., Balachandran, S., & Srinivasan, S. (2016). Antipsychotic use in dementia: A systematic review of benefits and risks from meta-analyses. Therapeutic Advances in Chronic Disease, 7(5), 229–245.CrossRefPubMedGoogle Scholar
  87. Tan, C. C., Yu, J. T., Wang, H. F., Tan, M. S., Meng, X. F., Wang, C., … Tan, L. (2014). Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis. Journal of Alzheimer’s Disease, 41(2), 615–631.CrossRefPubMedGoogle Scholar
  88. Teri, L., Gibbons, L. E., McCurry, S. M., Logsdon, R. G., Buchner, D. M., Barlow, W. E., … Larson, E. B. (2003). Exercise plus behavioral management in patients with Alzheimer disease: A randomized controlled trial. JAMA, 290(15), 2015–2022.CrossRefPubMedGoogle Scholar
  89. Thomas, P., Lalloué, F., Preux, P. M., Hazif-Thomas, C., Pariel, S., Inscale, R., … Clément, J. P. (2006). Dementia patients caregivers quality of life: The PIXEL study. International Journal of Geriatric Psychiatry, 21(1), 50–56.CrossRefPubMedGoogle Scholar
  90. United States Department of Health and Human Services. (2005). Glossary: Definition of restraints. Retrieved from http://www.medicare.gov/Glossary/ShownTerm.asp?Languge=English&term=restraints
  91. U.S. Food and Drug Administration. (2008). Information for Health Care Professionals: Conventional Antipsychotics. Retrieved from https://wayback.archiveit.org/7993/20170722190727/. https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124830.htm
  92. van der Spek, K., Gerritsen, D. L., Smalbrugge, M., Nelissen-Vrancken, M. H., Wetzels, R. B., Smeets, C. H., … Koopmans, R. T. (2016). Only 10% of the psychotropic drug use for neuropsychiatric symptoms in patients with dementia is fully appropriate. The PROPER I-study. International Psychogeriatrics, 28(10), 1589–1595.CrossRefPubMedGoogle Scholar
  93. Van Duijn, C. M., Clayton, D. G., Chandra, V., Fratiglioni, L., Graves, A. B., Heyman, A., … Rocca, W. A. (1994). Interaction between genetic and environmental risk factors for Alzheimer’s disease: A reanalysis of case-control studies. Genetic Epidemiology, 11(6), 539–551.CrossRefPubMedGoogle Scholar
  94. van Hout, H. P., Vernooij-Dassen, M. J., & Stalman, W. A. (2007). Diagnosing dementia with confidence by GPs. Family Practice, 24(6), 616–621.CrossRefPubMedGoogle Scholar
  95. Vance, D. E., & Struzick, T. C. (2007). Addressing risk factors of cognitive impairment in adults aging with HIV: A social work model. Journal of Gerontological Social Work, 49(4), 51–77.CrossRefPubMedGoogle Scholar
  96. Vasudev, A., Shariff, S. Z., Liu, K., Burhan, A. M., Herrmann, N., Leonard, S., & Mamdani, M. (2015). Trends in psychotropic dispensing among older adults with dementia living in long-term care facilities: 2004–2013. The American Journal of Geriatric Psychiatry, 23(12), 1259–1269.CrossRefPubMedGoogle Scholar
  97. Villars, H., Oustric, S., Andrieu, S., Baeyens, J. P., Bernabei, R., Brodaty, H., … Frisoni, G. (2010). The primary care physician and Alzheimer’s disease: An international position paper. The Journal of Nutrition, Health & Aging, 14(2), 110–120.CrossRefGoogle Scholar
  98. Wang, J., Yu, J. T., Wang, H. F., Meng, X. F., Wang, C., Tan, C. C., & Tan, L. (2014). Pharmacological treatment of neuropsychiatric symptoms in Alzheimer’s disease: A systematic review and meta-analysis. Journal of Neurology, Neurosurgery & Psychiatry, 86(1), 101–109 jnnp-2014.CrossRefGoogle Scholar
  99. Wetzels, R. B., Zuidema, S. U., De Jonghe, J. F. M., Verhey, F. R. J., & Koopmans, R. T. C. M. (2010). Determinants of quality of life in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders, 29(3), 189–197.CrossRefPubMedGoogle Scholar
  100. World Health Organization. (1997). Measuring quality of life. In Division of mental health and prevention of substance abuse. Geneva, Switzerland: World Health Organization.Google Scholar
  101. Yon, A., & Scogin, F. (2008). Behavioral activation as a treatment for geriatric depression. Clinical Gerontologist, 32(1), 91–103.CrossRefGoogle Scholar
  102. Yury, C. A., & Fisher, J. E. (2007). Meta-analysis of the effectiveness of atypical antipsychotics for the treatment of behavioural problems in persons with dementia. Psychotherapy and Psychosomatics, 76(4), 213–218.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Jonathan Singer
    • 1
  • Adrienne Chong
    • 1
  • Ryan Hisaka
    • 1
  • Jane E. Fisher
    • 1
  1. 1.Department of PsychologyUniversity of Nevada, RenoRenoUSA

Personalised recommendations